Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for VELSIPITY (etrasimod) in the European Union to treat patients 16 years...
MCRA, LLC, a leading medical device focused regulatory advisory firm and clinical research organization (CRO) integrating U.S. and International Regulatory Affairs, Clinical Trial Operations,...
Novavax, Inc, a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, announced that Nuvaxovid (NVX-CoV2373) has been recommended for full Marketing Authorization...
Mirum Pharmaceuticals, Inc. announced submission to the European Medicines Agency (EMA) of a variation application to the Marketing Authorization for LIVMARLI (maralixibat) oral solution,...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine has been...
